Search
Chemed Corp
CHEAdd to Watchlist
436.270USD
+0.250+0.06%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
5.98BMarket Cap
23.76P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Chemed Corp is 7.00, ranking 47 out of 76 in the Healthcare Providers & Services industry. The average price target is 576.00, with a high of 595.00 and a low of 550.00.
Analyst Rating
Based on
4
analysts
Buy
Current Rating
446.500
Target Price
+2.34%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Chemed Corp
CHE
4
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Chemed Corp's expected revenue for the next quarter?
Chemed Corp's expected revenue is 665.53M.
What is Chemed Corp's price target?
Analysts forecast that Chemed Corp's price target is USD 576.00, with the highest forecast at USD 595.00 and the lowest forecast at USD 550.00.
How have Chemed CorpCHE's recent earnings per share performed?
The market expectation was USD 4.85, while Chemed CorpCHE's earnings per share (EPS) for the previous quarter was USD 5.49. EPS for the next quarter is expected at USD 5.62.
What is the analyst rating for Chemed Corp?
Based on the ratings of Chemed Corp's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
